Jinxiu Yang

539 total citations
23 papers, 421 citations indexed

About

Jinxiu Yang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jinxiu Yang has authored 23 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jinxiu Yang's work include Angiogenesis and VEGF in Cancer (8 papers), Pulmonary Hypertension Research and Treatments (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Jinxiu Yang is often cited by papers focused on Angiogenesis and VEGF in Cancer (8 papers), Pulmonary Hypertension Research and Treatments (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Jinxiu Yang collaborates with scholars based in China and United States. Jinxiu Yang's co-authors include Xingxiang Wang, Yanan Chu, Pingping Zhang, Weiliang Tang, Yuangang Qiu, Wei Mao, Furong Zhang, Wei Mao, Liang Xia and Guosheng Fu and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Jinxiu Yang

21 papers receiving 414 citations

Peers

Jinxiu Yang
Jinxiu Yang
Citations per year, relative to Jinxiu Yang Jinxiu Yang (= 1×) peers Haoming Song

Countries citing papers authored by Jinxiu Yang

Since Specialization
Citations

This map shows the geographic impact of Jinxiu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinxiu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinxiu Yang more than expected).

Fields of papers citing papers by Jinxiu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinxiu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinxiu Yang. The network helps show where Jinxiu Yang may publish in the future.

Co-authorship network of co-authors of Jinxiu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jinxiu Yang. A scholar is included among the top collaborators of Jinxiu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinxiu Yang. Jinxiu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luan, Wenkang, et al.. (2025). IL-6 signaling is required for the development and regeneration of ear cartilage in microtia. Frontiers in Cell and Developmental Biology. 13. 1625058–1625058.
2.
Ye, Tianxin, et al.. (2025). Inhibition of P2X7 receptor mitigates atrial fibrillation susceptibility in isoproterenol-induced rats. Biochemical and Biophysical Research Communications. 749. 151340–151340.
3.
Ye, Tianxin, Jinxiu Yang, Yi Yu, et al.. (2024). Inhibition of the P2X7 receptor prevents atrial proarrhythmic remodeling in experimental post-operative atrial fibrillation. International Immunopharmacology. 129. 111536–111536. 4 indexed citations
4.
Wang, Haitao, Yang Zhang, Jinxiu Yang, et al.. (2024). Changes in subclinical cardiac abnormalities 1 Year after recovering from COVID-19 in patients without clinical cardiac findings. Heliyon. 10(5). e27380–e27380. 2 indexed citations
5.
Ye, Tianxin, Yi Yu, Yanan Chu, et al.. (2023). TRPV2 inhibitor tranilast prevents atrial fibrillation in rat models of pulmonary hypertension. Cell Calcium. 117. 102840–102840. 5 indexed citations
8.
Chu, Yanan, et al.. (2020). Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis. European journal of medical research. 25(1). 64–64. 98 indexed citations
9.
Yang, Jinxiu, et al.. (2019). RNA‐binding protein SFPQ cooperates with HDAC1 to suppress CD40 transcription in pulmonary adventitial fibroblasts. Cell Biology International. 44(1). 166–176. 10 indexed citations
10.
Yang, Jinxiu, et al.. (2018). The Role of RhoA in Neovascular-Related Functions of Endothelial Progenitor Cells Induced by AngiotensinⅡ. Cellular Physiology and Biochemistry. 47(6). 2498–2510. 3 indexed citations
11.
Xu, Xiao‐Ming, Li Wu, Qin Zhuang, et al.. (2016). Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway. Microvascular Research. 111. 25–31. 21 indexed citations
12.
Yang, Jinxiu, Junhua Ge, Bin Chen, et al.. (2016). Tanshinone II A Attenuates TNF-α-Induced Expression of VCAM-1 and ICAM-1 in Endothelial Progenitor Cells by Blocking Activation of NF-κB. Cellular Physiology and Biochemistry. 40(1-2). 195–206. 48 indexed citations
13.
Wang, Shuai, Jinxiu Yang, Bin Chen, et al.. (2015). Interruption of CD40 Pathway Improves Efficacy of Transplanted Endothelial Progenitor Cells in Monocrotaline Induced Pulmonary Arterial Hypertension. Cellular Physiology and Biochemistry. 36(2). 683–696. 15 indexed citations
14.
Yang, Jinxiu, et al.. (2015). Protective effects of tanshinone IIA on endothelial progenitor cells injured by tumor necrosis factor-α. Molecular Medicine Reports. 12(3). 4055–4062. 15 indexed citations
16.
Yang, Jinxiu, et al.. (2012). Zoledronate Attenuates Angiogenic Effects of Angiotensin II-Stimulated Endothelial Progenitor Cells via RhoA and MAPK Signaling. PLoS ONE. 7(10). e46511–e46511. 17 indexed citations
17.
Yang, Lin, Xiaogang Guo, Changqing Du, et al.. (2012). Interleukin-1 Beta Increases Activity of Human Endothelial Progenitor Cells: Involvement of PI3K-Akt Signaling Pathway. Inflammation. 35(4). 1242–1250. 26 indexed citations
18.
Tang, Weiliang, et al.. (2010). Suppression of tissue inhibitors of metalloproteinases may reverse severe pulmonary arterial hypertension. Cytotherapy. 13(4). 499–502. 5 indexed citations
19.
Yang, Jinxiu, Weiliang Tang, & Xingxiang Wang. (2010). Superparamagnetic iron oxide nanoparticles may affect endothelial progenitor cell migration ability and adhesion capacity. Cytotherapy. 12(2). 251–259. 50 indexed citations
20.
Xia, Liang, Guosheng Fu, Jinxiu Yang, Furong Zhang, & Xingxiang Wang. (2009). Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension. Cytotherapy. 11(4). 492–502. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026